Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Novo and Lilly are fighting for share in the global GLP-1 market, which surpassed $50 billion in 2024 and is likely to reach $200 billion by 2031 as supply and insurance coverage improve and more patients are treated globally, even as prices come down
Current pharmacological strategies for UC primarily include 5-aminosalicylic acid (5-ASA), glucocorticoids, thiopurines, biological medications, and anti-cytokine therapies (Lamb et al., 2019
Although typically solitary, rare patients may present with multifocal lesions.
A single bad week does not mean tirzepatide is making your migraines worse, just as a single good week does not mean it is helping
Tailor your drip to match your needs
Their journeys demonstrate that the timeline for GLP-1 drugs is not only about the medication itself, but also about how well the treatment is integrated into daily life
